Small Renal Masses Progressing to Metastases under Active Surveillance: A Systematic Review and Pooled Analysis

Por Smaldone, Marc C., Kutikov, Alexander, Egleston, Brian L., Canter, Daniel J., Viterbo, Rosalia, Chen, David Y.T., Jewett, Michael A., Greenberg, Richard E., Uzzo, Robert G.
Publicado no Cancer (2011)

mTOR inhibitor associated noninfectious pneumonitis in patients with renal cell cancer: management, predictors, and outcomes

Por Atkinson, Bradley J., Cauley, Diana H., Ng, Chaan, Millikan, Randall E., Xiao, Lianchun, Corn, Paul, Jonasch, Eric, Tannir, Nizar M.
Publicado em 2013

Comparison between Selective Clamping and Hilar Clamping during Minimally Invasive Partial Nephrectomy: A Systematic Review and Meta-Analysis

Por Feng QI, Yu-xiao ZHENG, Jian-zhong ZHANG, Hong CHENG, Shu-hui SI, Dong-liang CAO, You-sheng LU
Publicado em 2018-04-01

BAP1 hereditary cancer predisposition syndrome: a case report and review of literature

Por Klebe, Sonja, Driml, Jack, Nasu, Masaki, Pastorino, Sandra, Zangiabadi, Amirmasoud, Henderson, Douglas, Carbone, Michele
Publicado no Biomark Res (2015)

Prevalence of Baseline Chronic Kidney Disease in Patients Presenting with Solid Renal Tumors

Por Canter, Daniel, Kutikov, Alexander, Sirohi, Mohit, Street, Ryan, Viterbo, Rosalia, Chen, David YT, Greenberg, Richard E., Uzzo, Robert G.
Publicado em 2011

Glucocorticoids Suppress Renal Cell Carcinoma Progression by Enhancing Na,K-ATPase Beta-1 Subunit Expression

Por Huynh, Thu P., Barwe, Sonali P., Lee, Seung J., McSpadden, Ryan, Franco, Omar E., Hayward, Simon W., Damoiseaux, Robert, Grubbs, Stephen S., Petrelli, Nicholas J., Rajasekaran, Ayyappan K.
Publicado no PLoS One (2015)

Expression of cyclins A and D and p21((waf1/cip1)) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival

Por Aaltomaa, S, Lipponen, P, Ala-Opas, M, Eskelinen, M, Syrjänen, K, Kosma, V-M
Publicado em 1999

Rounding of low serum creatinine levels and consequent impact on accuracy of bedside estimates of renal function in cancer patients

Por Dooley, M J, Singh, S, Rischin, D
Publicado em 2004

Intestinal plastic repair for urinary bladder cancer

Por L. V. Shaplygin, N. V. Sitnikov, D. V. Furashov, V. I. Dronov, R. Ye. Segedin, V. A. Sidorov
Publicado em 2006-12-01

The Relationship between B7-H4 Expression and Clinicopathological Characteristics in Clinical Stage T1 Conventional Renal Cell Carcinoma

Por Jung, Suk Gun, Choi, Kyung Un, Lee, Sang Don, Lee, Zeong Zoo, Chung, Moon Kee
Publicado em 2011

Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells

Por Hamed, Hossein A, Das, Swadesh K, Sokhi, Upneet K, Park, Margaret A, Cruickshanks, Nichola, Archer, Kellie, Ogretmen, Besim, Grant, Steven, Sarkar, Devanand, Fisher, Paul B, Dent, Paul
Publicado em 2013

Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma

Por Gunnarsson, Orvar, Pfanzelter, Nicklas R, Cohen, Roger B, Keefe, Stephen M
Publicado no Cancer Manag Res (2015)

Renin angiotensin system deregulation as renal cancer risk factor

Por Sobczuk, Paweł, Szczylik, Cezary, Porta, Camillo, Czarnecka, Anna M.
Publicado no Oncol Lett (2017)

Biomarker discovery for renal cancer stem cells

Por Corrò, Claudia, Moch, Holger
Publicado no J Pathol Clin Res (2018)

Percentage of urinary albumin excretion and serum-free light-chain reduction are important determinants of renal response in myeloma patients with moderate to severe renal impairment

Por Sugihara, H, Chihara, D, Seike, K, Fukumoto, K, Fujisawaa, M, Suehara, Y, Nishida, Y, Takeuchi, M, Matsue, K
Publicado no Blood Cancer J (2014)

Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG)

Por Kuin, A, Rutgers, M, Valk, M A van der, Beijnen, J H, Smets, L A
Publicado em 1999

Caveolin 1 protein expression in renal cell carcinoma predicts survival

Por Steffens, Sandra, Schrader, Andres J, Blasig, Hanna, Vetter, Gesa, Eggers, Hendrik, Tränkenschuh, Wolfgang, Kuczyk, Markus A, Serth, Jürgen
Publicado em 2011

Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma

Por Wang Yong, Zhang Rui, Wu Donglu, Lu Zhihua, Sun Wentao, Cai Yong, Wang Chunxi, Jin Jingji
Publicado em 2013-02-01

FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines

Por Su, Ke, Zeng, Ping, Liang, Wei, Luo, Zhengyu, Wang, Yiman, Lv, Xifeng, Han, Qi, Yan, Miao, Chen, Cheng
Publicado no Mediators Inflamm (2017)

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer

Por Fearon, Abbie E., Carter, Edward P., Clayton, Natasha S., Wilkes, Edmund H., Baker, Ann-Marie, Kapitonova, Ekaterina, Bakhouche, Bakhouche A., Tanner, Yasmine, Wang, Jun, Gadaleta, Emanuela, Chelala, Claude, Moore, Kate M., Marshall, John F., Chupin, Juliette, Schmid, Peter, Jones, J. Louise, Lockley, Michelle, Cutillas, Pedro R., Grose, Richard P.
Publicado no Cell Rep (2018)